Your browser doesn't support javascript.
loading
Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection.
Prabhu, Vimalanand S; Dubberke, Erik R; Dorr, Mary Beth; Elbasha, Elamin; Cossrow, Nicole; Jiang, Yiling; Marcella, Stephen.
Afiliação
  • Prabhu VS; Merck & Co, Inc, Kenilworth, New Jersey.
  • Dubberke ER; Washington University, St Louis, Missouri.
  • Dorr MB; Merck & Co, Inc, Kenilworth, New Jersey.
  • Elbasha E; Merck & Co, Inc, Kenilworth, New Jersey.
  • Cossrow N; Merck & Co, Inc, Kenilworth, New Jersey.
  • Jiang Y; Merck Sharp & Dohme Ltd, Hoddesdon, Hertfordshire, United Kingdom.
  • Marcella S; Merck & Co, Inc, Kenilworth, New Jersey.
Clin Infect Dis ; 66(3): 355-362, 2018 01 18.
Article em En | MEDLINE | ID: mdl-29106516
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Clostridium / Anticorpos Neutralizantes / Antibacterianos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Clostridium / Anticorpos Neutralizantes / Antibacterianos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article